GZMK and benign prostatic hyperplasia: Overall, these data show that granzyme K can modulate SASP-associated factor secretion by BPH-derived fibroblasts and suggests that granzyme K may impact the prostate inflammatory microenvironment by promoting inflammatory cytokine production by both cycling and senescent prostate stromal fibroblasts.